Trial Profile
A phase I trial to compare the safety and immunogenicity of candidate TB vaccine MVA85A administered by the aerosol inhaled route and the intradermal route in healthy BCG vaccinated adult subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs MVA 85A (Primary) ; MVA 85A (Primary)
- Indications Tuberculosis
- Focus Adverse reactions; Pharmacodynamics
- 01 Apr 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 18 Dec 2012 Status changed from recruiting to active, no longer recruiting as reported by United Kingdom Clinical Research Network.
- 15 Nov 2012 Accrual to date is 100% according to United Kingdom Clinical Research Network.